MARY ADAMS: Open Payments
NPI 1003179946 · COMMERCE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 45 payments from 18 companies in 2025. Trend: 2023 $708 · 2024 $930 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $117 |
| PFIZER INC. | 5 | $97 |
| Amgen Inc. | 5 | $94 |
| Novo Nordisk Inc | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Lundbeck LLC | 2 | $50 |
| Axsome Therapeutics, Inc. | 3 | $47 |
| Exact Sciences Corporation | 2 | $30 |
Products named: REXULTI, NURTEC ODT, OTEZLA, TRINTELLIX, FANAPT, Wegovy, Auvelity, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
